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Abstract
In order to better understand the mechanism(s) of action of carbamazepine (CBZ), we studied its effects on the increase in
[Ca2]i and [Na
]i stimulated by glutamate ionotropic receptor agonists, in cultured rat hippocampal neurons, as followed by
indo-1 or SBFI fluorescence, respectively. CBZ inhibited the increase in [Ca2]i stimulated either by glutamate, kainate,
a-amino-3-hydroxy-5-methyl-isoxazole-4-propionate (AMPA), or N-methyl-D-aspartate (NMDA), in a concentration-dependent
manner. In order to discriminate the effects of CBZ on the activation of glutamate receptors from possible effects on Ca2
channels, we determined the inhibitory effects of Ca2 channel blockers on [Ca2]i changes in the absence or in the presence of
CBZ. The presence of 1 mM nitrendipine, 0.5 mM v-conotoxin GVIA (v-CgTx GVIA), or of both blockers, inhibited the
kainate-stimulated increase in [Ca2]i by 51.6, 32.9 or 68.7%, respectively. In the presence of both 100 mM CBZ and nitrendipine,
the inhibition was similar (54.1%) to that obtained with nitrendipine alone, but in the presence of both CBZ and v-CgTx GVIA,
the inhibition was greater (54%) than that caused by v-CgTx GVIA alone. However, CBZ did not inhibit the increase in [Na]i
stimulated by the glutamate receptor agonists, but inhibited the increase in [Na]i due to veratridine. Tetrodotoxin, or MK-801,
did not inhibit the influx of Na stimulated by kainate, indicating that Na influx occurs mainly through the glutamate
ionotropic non-NMDA receptors. Moreover, LY 303070, a specific AMPA receptor antagonist, inhibited the [Na]i response to
kainate or AMPA by about 70 or 80%, respectively, suggesting that AMPA receptors are mainly involved. Taken together, the
results suggest that CBZ inhibits L-type Ca2 channels and Na channels, but does not inhibit activation of glutamate
ionotropic receptors. © 1999 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Carbamazepine (CBZ) is an antiepileptic drug (AED)
that has been extensively used in neurology in the
treatment of epilepsies and trigeminal neuralgia, and in
psychiatry for the prophylatic treatment of affective
and schizoaffective psychosis. CBZ limits sustained
high-frequency repetitive-firing of sodium-dependent
action potentials of central neurons in cell culture at
therapeutic concentrations (MacDonald and Kelly,
1993; Morimoto et al., 1997). This effect is commonly
ascribed to a voltage-dependent inhibitory effect on
voltage-gated Na channels (Kapetanovic et al., 1995;
Kuo et al., 1997; Rush and Elliott, 1997). However, the
mechanisms underlying the effects of this AED have
not been completely identified, and are still a matter of
debate. It has been shown that CBZ can inhibit Ca2
channels (Elliott, 1990; Schirrmacher et al., 1993; Schu-
macher et al., 1998), enhance 4-aminopyridine-sensitive
potassium currents in cortical neurons (Olpe et al.,
1991), acts as an antagonist of adenosine A1 receptors
(Biber et al., 1996), attenuates cAMP production (Chen
et al., 1996), induces the release of serotonin (Dailey et
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al., 1997a,b), and inhibits the release of glutamate
(Waldmeier et al., 1996; Okada et al., 1998). Preischemic
treatment with CBZ also tends to reduce the cerebral
damage and neurological deficit (Minato et al., 1997).
The demonstration by Croucher et al. (1982) that
N-methyl-D-aspartate (NMDA) receptor antagonists
had powerful anticonvulsant activity in a variety of
animal seizure models, firmly established the concept
that NMDA receptors play an important role in epilep-
tic phenomena. More recently, the availability of selec-
tive non-NMDA receptor antagonists has made it
possible to demonstrate that non-NMDA receptors also
participate in seizure generation and are potential
targets for antiepileptic drugs (Turski et al., 1987;
Lo¨scher, 1998). Various lines of evidence indicate that
CBZ inhibits NMDA-induced responses (Lampe and
Bigalpe, 1990; Gean et al., 1993; Hough et al., 1996).
However, very little is known about the effect of CBZ
on non-NMDA receptors. Considering this, and that the
hippocampus has the highest density of kainate-binding
sites in the brain (Ben-Ari, 1985), in the present work we
investigated the effect of CBZ on [Ca2]i and [Na]i
signals stimulated by ionotropic glutamate receptor ago-
nists in cultured rat hippocampal neurons, in order to
better understand the mechanism(s) of action of CBZ.
The results indicate that CBZ inhibits L-type Ca2
channels, which are activated subsequent to membrane
depolarization due to glutamate receptor activation, at
least at concentrations above 30 mM, but does not affect
glutamate ionotropic receptor activation. A preliminary
account of this work has been presented (Ambro´sio et
al., 1998).
2. Methods
2.1. Preparation and culture of hippocampal neurons
To prepare the hippocampal neurons in culture, cells
were dissociated from hippocampi of E18-E19 Wistar
rat embryos, after treatment with trypsin (0.5 mg:ml, 15
min, 37°C) and deoxyribonuclease I (0.20 mg:ml) in
Ca2- and Mg2-free Hank’s balanced salt solution
(137 mM NaCl, 5.36 mM KCl, 0.44 mM KH2PO4, 0.34
mM Na2HPO4·2H2O, 4.16 mM NaHCO3, 5 mM glu-
cose, supplemented with 0.001% phenol red, 1 mM
sodium pyruvate, 10 mM Hepes, pH 7.4). The cells were
cultured in serum-free Neurobasal medium (GIBCO),
supplemented with B27 supplement (GIBCO), gluta-
mate (25 mM), glutamine (0.5 mM) and gentamicin (0.12
mg:ml). This procedure produces a nearly pure neuronal
population as glial growth is reduced (Brewer et al.,
1993). Cultures were kept at 37°C in a humidified
incubator in 5% CO2:95% air, for 7–8 days, the time
required for maturation of hippocampal neurons.
Cells were plated on poly-D-lysine-coated (0.1 mg:ml)
glass coverslips at a density of 0.2x106 cells:cm2 for
indo-1 and SBFI fluorescence.
2.2. [Ca2]i measurements
Measurements of [Ca2]i were carried out in popula-
tions of hippocampal neurons cultured on glass cover-
slips at a density of 0.2106 cells:cm2. The cells were
incubated with 3 mM indo-1:AM in Krebs buffer (132
mM NaCl, 4 mM KCl, 1.4 mM MgCl2, 1 mM CaCl2,
6 mM glucose, 10 mM Hepes–Na, pH 7.4) for 40 min
at 37°C, and the cells were further incubated for 20 min
in Krebs buffer to obtain a complete hydrolysis of
indo-1:AM. The coverslips were rinsed with Krebs
buffer and mounted, with a special holder (Perkin-Elmer
L2250008), in a temperature-controled cuvette. The
fluorescence was monitored with a Spex Fluoromax
spectrofluorometer, with excitation at 335 nm and emis-
sion at 410 nm, using 5 nm slits. The [Ca2]i was
calculated with the following equation (Gelfand et al.,
1986):
[Ca2]i250 (FFmin):(FmaxF), where
FminAF1:12(FmaxAF)
The value of Fmax was calculated upon addition of 3 mM
ionomicin and the autofluorescence (AF) was measured
in the presence of 3 mM MnSO4.
Hippocampal neurons were incubated with the drugs
10 min before stimulation with the ionotropic glutamate
receptor agonists until the end of each experiment. The
calibration was made 100 s after stimulation with the
agonists, using ionomicin and MnSO4.
2.3. SBFI fluorescence measurements
Measurements of SBFI fluorescence were carried out
in populations of hippocampal neurons cultured on
glass coverslips at a density of 0.2106 cells:cm2. The
cells were incubated with 10 mM SBFI:AM and 0.2%
Pluronic F-127, in Krebs buffer (132 mM NaCl, 4 mM
KCl, 1.4 mM MgCl2, 1 mM CaCl2, 6 mM glucose, 10
mM Hepes–Na, pH 7.4), for 150 min at 37°C, followed
by 15 min in Krebs buffer without SBFI:AM. The
coverslips were rinsed with Krebs buffer and mounted,
with a special holder (Perkin-Elmer L2250008), in a
temperature-controled cuvette. The fluorescence was
monitored with a Spex Fluoromax spectrofluorometer,
with excitation wavelengths of 340 and 380 nm (in the
ratio mode) and emission at 505 nm, with excitation and
emission slits of 5 and 10 nm, respectively. Hippocampal
neurons were incubated with the drugs at least 5 min
before stimulation with the ionotropic glutamate recep-
tor agonists until the end of each experiment. The
variation of the excitation fluorescence ratio represents
the difference between the values obtained 200 s after
stimulation and basal values.
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2.4. Chemicals
Carbamazepine (CBZ) was obtained from BIAL (S.
Mamede do Coronado, Portugal). Glutamate, DNase
(DN-25) and tetrodotoxin (TTX) were purchased from
Sigma Chemical, St. Louis, MO, USA. Kainate, a-
amino-3-hydroxy-5-methyl-isoxazole-4-propionate
(AMPA) and N-methyl-D-aspartate (NMDA) were
purchased from TOCRIS, Ballwin, MO 63011, USA.
Nitrendipine was a kind gift of Dr G. Terstappen, from
Bayer A.G, Germany. v-conotoxin GVIA (v-CgTx
GVIA) was obtained from Peninsula Laboratories, Bel-
mont, CA, USA and v-Agatoxin IVA (v-Aga IVA)
was from Peptide Institute, INC., Osaka, Japan. LY
303070 was a kind gift of Lilly Research Laboratories,
Indianapolis, IN 46285, USA. MK-801 was a kind gift
of Merck Sharp and Dohme, USA. The acetoxymethyl
esters of indo-1 (indo-1:AM) and SBFI (SBFI:AM)
were purchased from Molecular Probes, Eugene, OR,
USA. Ionomycin was purchased from Calbiochem-
Boehringer, San Diego, USA. Neurobasal medium, B27
supplement and trypsin (USP grade) were purchased
from GIBCOBRL, Life Technologies, Paisley PA4
9RF, Scotland. All other reagents were from Sigma
Chemical, St. Louis, MO, USA or from Merck-
Schuchardt, Germany.
CBZ, nitrendipine, LY 303070, indo-1:AM, SBFI:
AM and ionomycin stock solutions were prepared in
DMSO.
2.5. Statistical analysis
The data are expressed as means 9S.E.M. Statistical
significance was determined by using an analysis of
variance (ANOVA), followed by Dunnett’s or Bonfer-
roni’s post-tests, or with Student’s t-test, as indicated in
the figure legends.
3. Results
3.1. Characterization of the [Ca2]i response
stimulated by glutamate ionotropic receptor agonists in
cultured hippocampal neurons
We determined the alterations in the [Ca2]i stimu-
lated by glutamate ionotropic receptor agonists (gluta-
mate, kainate, AMPA or NMDA) and found that the
maximal change in [Ca2]i caused by the agonists was
232.3 nM (n5), 165.5 nM (n7), 166.5 nM (n7)
and 74.2 nM (n6), for glutamate, kainate, AMPA
and NMDA, respectively (Figs. 1 and 2). The [Ca2]i
Fig. 1. Representative traces showing the increase in [Ca2]i stimulated by 100 mM of either glutamate (Glu), kainate, AMPA or NMDA, in
cultured rat hippocampal neurons. The maximal change (average) in the [Ca2]i, for the four agonists tested, was 232.3 nM (n5), 165.5 nM
(n7), 166.5 nM (n7) and 74.2 nM (n6), respectively, and represents the difference between peak and basal [Ca2]i values. When the cells
were stimulated with NMDA the experiments were performed in the absence of Mg2. The [Ca2]i was determined by using indo-1 fluorescence,
and the equation developed by Gelfand et al. (1986), as indicated in Section 2.
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Fig. 2. Concentration-response curves for the effects of glutamate (Glu), kainate, AMPA or NMDA on peak [Ca2]i changes (D[Ca2]i). The
EC97 values determined were 223.0 mM for Glu, 185.4 mM for KA, 201.4 mM for AMPA and 217.0 mM for NMDA. The EC50 for each agonist
was 38.691.6, 22.091.4, 20.591.5 and 33.792.1 mM, respectively. When the cells were stimulated with NMDA, experiments were performed
in the absence of Mg2. The curves indicate the best fits according to nonlinear regression analysis (sigmoidal dose-response curve). The results
represent the mean 9S.E.M. of at least five independent experiments.
changes represent the difference between peak and
basal [Ca2]i values. The experiments with NMDA
were performed in the absence of Mg2. The calculated
EC97 values were 223.0 mM for glutamate, 185.4 mM for
kainate, 201.4 mM for AMPA and 217.0 mM for
NMDA. The calculated EC50 values for each agonist
were 38.691.6, 22.091.4, 20.591.5 and 33.792.1
mM, respectively.
3.2. Inhibition by CBZ of the [Ca2]i response
stimulated by glutamate ionotropic receptor agonists
We determined the concentration-dependency effect
of CBZ against glutamate, kainate, AMPA and
NMDA utilized at the corresponding EC97 values deter-
mined above. CBZ inhibited the increase in the [Ca2]i
induced by the glutamate receptor agonists in a dose-
dependent manner (Fig. 3). The inhibitory effect of
CBZ was greater in glutamate-stimulated neurons, as
compared to the stimulation induced by the other ago-
nists, probably because in glutamate-stimulated neu-
rons the alterations in the [Ca2]i are greater. Thus,
CBZ (500 mM), the highest concentration utilized, in-
hibited the increase in the [Ca2]i stimulated by 223.0
mM glutamate by 62.794.9%. In NMDA-stimulated
neurons, only concentrations of CBZ above 100 mM
caused an inhibition of the response, and the inhibition
caused by 500 mM CBZ was 43.193.2%. The inhibi-
tion caused by 500 mM CBZ in hippocampal neurons
stimulated either with kainate or AMPA was 52.294.5
or 47.491.6%, respectively.
3.3. Characterization of the inhibitory effect caused by
CBZ in kainate-stimulated neurons
Non-NMDA receptors have been implicated in
epilepsy (Rogawski, 1995; Lo¨scher, 1998). Kainate, a
potent neurotoxin widely used in epilepsy studies, has a
very high number of binding sites in the hippocampus
(Ben-Ari, 1985). We found that the increase in the
[Ca2]i due to stimulation with 100 mM kainate was
inhibited by 60% in the presence of 15 mM LY 303070,
a non-competitive AMPA receptor antagonist (not
shown), suggesting that kainate-induced responses may
be mediated by the activation of AMPA receptors.
Considering that activation of ionotropic glutamate
receptors could lead to the opening of voltage-sensitive
Ca2 channels (VSCCs), we investigated the contribu-
tion of different types of VSCCs to the increase in the
[Ca2]i, due to stimulation with kainate (185.4 mM,
EC97). The contribution of each Ca2 channel type was
determined in the presence of saturating concentrations
of the three Ca2 channel blockers utilized (Ambro´sio
et al., 1997). Thus, the increase of [Ca2]i stimulated by
kainate was inhibited by 51.692.8% in the presence of
1 mM nitrendipine (L-type Ca2 channel blocker), and
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by 32.991.3% in the presence of v-CgTx GVIA (0.5
mM), an N-type Ca2 channel blocker (Fig. 4). The
presence of both blockers caused an inhibition of
68.792.9%. The P:Q-type Ca2 channel blocker, v-
Aga IVA (100 nM) did not inhibit the increase of the
[Ca2]i in these cells.
Since the presence of the Ca2 channel blockers did
not completely block the increase of the [Ca2]i caused
by kainate, we checked other possible routes for the
entry of Ca2. In order to investigate whether AMPA:
kainate receptors, present in our preparation, were
permeable to Ca2, we stimulated the hippocampal
neurons with kainate in N-methyl-D-glucamine
(NMG)-medium, where Na is replaced by NMG,
which does not enter into the cells, and we did not
observe any increase in the [Ca2]i (not shown), indi-
cating that in this preparation kainate or AMPA recep-
tors are not permeable to Ca2.
Contrary to what we found for AMPA:kainate re-
ceptors, NMDA receptors in CNS neurons are highly
permeable to Ca2 (Ozawa, 1996). Considering also
that activation of AMPA:kainate receptors could lead
to membrane depolarization which, in turn, may un-
block the NMDA receptor, we analysed the effect of
MK-801 (10 mM), an antagonist of NMDA receptors,
on the [Ca2]i increase caused by kainate. Fig. 5 shows
that MK-801 did not have any effect (Mg2 present in
the medium), indicating that NMDA receptors do not
contribute to the increase in the [Ca2]i under these
conditions of stimulation.
Carbamazepine (100 mM) inhibited the [Ca2]i in-
crease stimulated with kainate by 41.094.2%. The
inhibition caused by the presence of both CBZ and
nitrendipine (54.196.5%) was similar to that caused by
nitrendipine alone (51.692.8%). This result suggests
that CBZ and nitrendipine are both acting on L-type
Ca2 channels. However, the inhibition produced in
Fig. 3. Inhibition curves for the effect of CBZ on the [Ca2]i increase (% of control) due to glutamate receptor agonists. The agonist concentration
chosen was the EC97 value in each case, as determined in Fig. 2: 223.0 mM glutamate (Glu), 185.4 mM kainate (KA), 201.4 mM AMPA or 217.0
mM NMDA. The curves represent the best fit according to nonlinear regression analysis (one site competition). The results represent the mean
9S.E.M. of at least four independent experiments.
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Fig. 4. Effect of the Ca2 channel blockers nitrendipine (Nit, 1 mM),
v-CgTx GVIA (CgTx, 0.5 mM), v-Agatoxin IVA (AgaIVA, 0.1 mM)
and:or CBZ (100 mM) on the [Ca2]i increase stimulated by 185.4
mM kainate (EC97; KA), in cultured rat hippocampal neurons. The
cells were incubated with the Ca2 channel blockers for 15 min
before starting the [Ca2]i measurements. The results represent the
mean 9S.E.M of at least five independent experiments. ** PB0.01,
Dunnett’s post-test;   PB0.01 ,Bonferronis’s post-test; statistical
significance when compared to 185.4 mM KA or 0.5 mM v-CgTx
GVIA, respectively.
target. Moreover, the inhibitory effect obtained in the
presence of both CBZ, nitrendipine and v-CgTx GVIA
(67.194.7%) was similar to that caused by a combina-
tion of both Ca2 channel blockers (68.792.9%), in
the absence of CBZ. In these studies, we used 100 mM
CBZ, since at this concentration CBZ significantly in-
hibited the response and is similar to the therapeutic
range, i.e. plasma levels of 17–51 mM (Rogawski and
Porter, 1990).
CBZ is known to inhibit voltage-sensitive Na chan-
nels (VSSCs) (Kuo et al., 1997; Rush and Elliott, 1997).
We therefore investigated the role of voltage-sensitive
Na channels on the increase in the [Ca2]i, induced
by kainate. Tetrodotoxin (1 mM), a blocker of VSSCs,
did not cause any inhibition of the kainate effect,
suggesting that these channels are not involved in the
depolarization caused by kainate. Moreover, the inhibi-
tion caused by the presence of both CBZ and TTX is
similar to that obtained with CBZ (Fig. 5). These
results also indicate that the inhibitory effect of CBZ is
not mediated through the inhibition of tetrodotoxin-
sensitive Na channels.
Thus, the results suggest that the main route for the
entry of Ca2 when the hippocampal neurons are
stimulated with kainate are the VSCCs, namely L- and
N-type Ca2 channels, and the inhibitory effect caused
by CBZ may be mediated by the inhibition of these
channels, namely the L-type Ca2 channels.
3.4. Characterization of the Na influx stimulated by
glutamate ionotropic receptor agonists
We observed that the increase in the SBFI excitation
fluorescence ratio (F340 nm:F380 nm), as a measure of the
[Na]i changes, is greater in hippocampal neurons
stimulated with 100 mM glutamate as compared to 100
mM of either kainate, AMPA or NMDA (Fig. 6), and
was, respectively (arbitrary units) 0.20590.011 (n
11), 0.16090.007 (n18), 0.15090.005 (n12) or
0.07590.006 (n11). We then characterized the ef-
fects of CBZ on the [Na]i responses mediated by
non-NMDA receptors in hippocampal neurons. Thus,
when hippocampal neurons were stimulated either with
100 mM of kainate or 100 mM AMPA, the elicited
[Na]i response was inhibited by 15 mM LY 303070 by
67.692.9 or 79.193.5%, respectively (Fig. 7). These
results suggest that the Na entry stimulated by
kainate is essentially mediated by the activation of
AMPA receptors. We also investigated the contribution
of voltage-sensitive Na channels and of NMDA re-
ceptors for the [Na]i signal stimulated by kainate, and
observed that 1 mM TTX or 10 mM MK-801 (Mg2
present in the medium) did not have any effect on the
[Na]i signal (Fig. 7). These results indicate that
NMDA receptors and voltage-sensitive Na channels
do not contribute significantly to the influx of Na,
Fig. 5. Effect of MK-801 (MK, 10 mM), TTX (1 mM), CBZ (300 mM)
and CBZ plus TTX on the [Ca2]i signal stimulated by 185.4 mM
kainate (EC97, KA), in cultured rat hippocampal neurons. The exper-
iments were performed in the presence of Mg2. The results repre-
sent the mean 9S.E.M of at least five independent experiments.
** PB0.01; statistical significance when compared to 185.4 mM KA
(Dunnett’s post-test).
the presence of both CBZ and v-CgTx GVIA (54.09
4.5%) was greater than that caused by v-CgTx GVIA
alone (32.991.3%). This additive effect suggests that
other types of Ca2 channels different from the N-
type, for example L-type Ca2 channels, can be the
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Fig. 6. Representative traces reflecting the increase in the [Na]i due to stimulation with 100 mM glutamate (Glu), kainate, AMPA or NMDA,
in cultured rat hippocampal neurons, as followed by the excitation fluorescence ratio (340:380 nm) of SBFI. When cells were stimulated with
NMDA the experiments were performed in the absence of Mg2. The experiments were performed as described in Section 2.
and the main route of Na entry is the AMPA recep-
tor channel.
3.5. Effect of carbamazepine on the [Na]i signal
CBZ (300 mM) did not inhibit the influx of Na
stimulated by 100 mM of either glutamate, kainate,
AMPA or NMDA (Fig. 8), suggesting that CBZ, in our
preparation, does not affect glutamate ionotropic re-
ceptors. We also analysed the effect of CBZ on the
[Na]i signal stimulated by veratridine (25 mM), a Na
channel opener. CBZ inhibited the response by about
50% (not shown), confirming that CBZ also acts on
Na channels, and may interfere with these channels
when they are specifically activated.
4. Discussion
CBZ blocks NMDA-induced currents in cultured
spinal cord neurons (Lampe and Bigalpe, 1990), in-
hibits NMDA-induced depolarizations in cortical
wedges prepared from DBA:2 mice (Lancaster and
Davies, 1992), antagonizes convulsions produced by
intracerebroventricular administration of NMDA
(Sofia et al., 1994), and inhibits NMDA-evoked cal-
cium influx in rat cerebellar granule cells (Hough et al.,
1996). However, the inhibition caused by CBZ on
NMDA-mediated responses appear to be independent
of the NMDA and glycine recognition sites. Grant et
al. (1992) showed that CBZ was inactive in displacing
[3H]dizocilpine at concentrations substantially higher
Fig. 7. Identification of the pathways of Na entry in cultured rat
hippocampal neurons, stimulated with kainate (KA, 100 mM) or
AMPA (100 mM). Hippocampal neurons were stimulated with KA in
the presence of either LY 303070 (LY, 15 mM), tetrodotoxin (TTX, 1
mM) or MK-801 (MK, 10 mM), and with AMPA (100 mM) in the
presence of LY 303070 (15 mM). The results represent the mean
9S.E.M. of at least four independent experiments. ** PB0.01,
Dunnett’s post-test; *** PB0.0001, Sudent’s t-test; statistical signifi-
cance when compared to 100 mM KA or 100 mM AMPA, respec-
tively.
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Fig. 8. Absence of effect of CBZ (300 mM) on the Na influx
stimulated by 100 mM of either glutamate (Glu), kainate (KA),
AMPA or NMDA, in cultured rat hippocampal neurons. The exper-
iments were performed as described in Section 2. The results represent
the mean 9S.E.M. of at least four independent experiments.
4.2. Effect of CBZ on kainate-mediated [Ca2]i
responses
In the present work we extensively explored the effect
of CBZ on the [Ca2]i changes due to kainate stimula-
tion. Cai and McCaslin (1992) reported for the first
time an interaction of tricyclic compounds with the
function of glutamate receptors in concentrations used
therapeutically, showing that CBZ prevented the eleva-
tion of the [Ca2]i induced by kainate. More recently,
it was shown that CBZ also attenuated responses to
AMPA in the rat cortical wedge (Phillips et al., 1997).
We found that the responses caused by kainate stimula-
tion are mainly due to AMPA receptor activation, and
that L-type and N-type Ca2 channels have a predom-
inant role in the increase in the [Ca2]i. The presence of
both N- and L-type Ca2 channel blockers inhibited
the response by about 70%. Previous reports also show
that L-type Ca2 channels are activated upon stimula-
tion with kainate (Murphy and Miller, 1989; Courtney
et al., 1990). Concerning N-type Ca2 channels there is
no direct evidence showing an inhibitory effect pro-
duced by v-CgTx GVIA in kainate-stimulated neurons.
However, in our preparation it is clear that N-type
Ca2 channels are implicated in the alterations in the
[Ca2]i. Furthermore, it was previously shown that
these channels play a small but significant role in
neurotransmiter release induced by kainate (Keith et
al., 1989). P-type Ca2 channels, which are predomi-
nantly located in nerve terminals (Ambro´sio et al.,
1997) did not contribute to the increase in the [Ca2]i
in the hippocampal cell cultures, probably because we
are mainly looking at changes in neuronal cell bodies.
R-type Ca2 channels, which are essentially located in
cell bodies (Yokoyama et al., 1995), could also be
activated after a kainate stimulus. Unfortunatly, we
could not check the contribution of R-channels, since
Ni2, which is a specific blocker, at least at lower
concentrations, interfered with the fluorescence
recordings.
Since AMPA:kainate receptors may be permeable to
Ca2, depending on the subunit composition, and
NMDA receptors are highly permeable to Ca2 (Lu et
al., 1996), we checked whether Ca2 could be entering
through these receptors. Stimulation of hippocampal
neurons with kainate in NMG-medium, or stimulation
in the presence of MK-801 (Mg2 present), showed
that these receptors do not contribute, at least signifi-
cantly, to the increase in the [Ca2]i. It is important to
note that endogenous glutamate can be released after
stimulation with kainate and activate NMDA receptors
(Malva et al., 1996). More recent evidence also suggests
that ionotropic receptor-mediated Ca2 signals in neu-
rons might also involve release of Ca2 from intracellu-
lar stores (Berridge, 1998). However, the present study
clearly demonstrates that VSCCs have a predominant
than the therapeutic brain levels. Non-NMDA recep-
tors are also involved in epileptiform activity (Ro-
gawski, 1995; Lo¨scher, 1998). Since little is known
about the effect of CBZ on the responses mediated by
non-NMDA receptors, we studied the effect of CBZ on
the [Ca2]i and [Na]i signals stimulated by glutamate
ionotropic receptor agonists in order to better under-
stand the mechanism(s) of action of this AED.
4.1. Alterations in the [Ca2]i stimulated by glutamate
ionotropic receptor agonists
First of all, we determined the alterations in [Ca2]i
stimulated either by glutamate, kainate, AMPA or
NMDA, and found that the maximal change in [Ca2]i
was produced by glutamate, probably because it can
activate both NMDA and non-NMDA receptors. The
inhibitory effect of CBZ on glutamate-, kainate- or
AMPA-induced [Ca2]i increases was similar, with
some minor differences in the curve shape. CBZ caused
a significant inhibition of the response only above 30
mM, but the effect was more pronounced in glutamate-
stimulated neurons, at least with 300 and 500 mM CBZ,
when compared to the effect on the responses evoked
by the other agonists. This may be due to the higher
[Ca2]i alterations observed in glutamate-stimulated
neurons. We could not determine the IC50 values, since
at concentrations above 500 mM the drug precipitated.
The effect of CBZ on the NMDA-evoked [Ca2]i was
different, since only concentrations above 100 mM CBZ
produced an inhibitory effect, and the effect was
smaller (Fig. 3). So, it seems that the extent of [Ca2]i
alterations may be important for the effect of CBZ.
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role in these signals, namely L- and N-type Ca2
channels (Fig. 4).
The inhibition obtained when both CBZ (100 mM)
and nitrendipine were present was similar to the inhibi-
tion caused by the L-type Ca2 channel blocker alone.
These data indicate that CBZ, at least at higher concen-
trations, can affect L-type Ca2 channels, and agree
with other findings indicating that CBZ could have
Ca2 antagonistic properties (Elliott, 1990; Schirrma-
cher et al., 1993; Mark et al., 1995; Vonwegerer et al.,
1997; Schumacher et al., 1998). Moreover, Schirrma-
cher et al. (1995) also suggested that CBZ reduces Ca2
currents presumably by inhibiting L-type Ca2 chan-
nels in rat sensory spinal ganglion cells.
The inhibition obtained in the presence of v-Cgtx
GVIA plus CBZ is greater (54%) as compared to the
inhibition caused by the N-type Ca2 channel blocker
alone (33%), with the additional presence of CBZ not
enhancing the inhibitory effect caused by both L- and
N-type Ca2 channel blockers. The additive effect of
both CBZ and v-CgTx GVIA further suggests that
L-type Ca2 channels can be the target for CBZ, but
we cannot exclude the possibility that N-type Ca2
channels can also be affected, since the effect is not
completely additive. If they were affected however, the
effect would be very small, because we observed that in
the presence of nitrendipine, CBZ did not cause an
additional inhibitory effect, as would be expected if
N-type Ca2 channels were also a target. However,
Yoshimura et al. (1998) showed that CBZ inhibits high
K-evoked secretion of catecholamines by interfering
with N-type VSCCs. As mentioned above, the effects of
CBZ were studied at a concentration of 100 mM, since
the inhibitory effects were significant at this concentra-
tion, and because this concentration approximates to
the plasma levels of 17–51 mM (Rogawski and Porter,
1990). Sayer et al. (1993) observed that CBZ produced
a slight decrease in Ca2 currents in cortical neurons,
but only at concentrations of the order of 100 mM.
Since CBZ is known to inhibit voltage-sensitive Na
channels (Kuo et al., 1997; Rush and Elliott, 1997), the
effect observed previously could be due to a reduction
of the extent of depolarization. Thus, we analyzed the
role of TTX-sensitive Na channels on the increase of
the [Ca2]i induced by kainate, and found that they are
not involved in the depolarization caused by kainate,
probably because they inactivate after the onset of
depolarization. There are also TTX-insensitive and
TTX-resistant Na channels, but they are mainly
found in preparations of the peripheral nervous system,
and not from those of the CNS (Yoshida, 1994; Scholz
et al., 1998). High K directly opens Ca2 channels
without Na influx. We did not analyze the effect of
CBZ on K-stimulated neurons, since in kainate-stim-
ulated neurons TTX-sensitive Na channels are also
not involved, and because it is clear that VSCCs play
an important role.
4.3. Effect of CBZ on [Na]i signals
We also studied the effect of CBZ on the increase in
[Na]i stimulated by glutamate ionotropic receptor ag-
onists. As for the [Ca2]i measurements, we found that
the responses evoked by kainate are mainly mediated
by AMPA receptor activation, since they are sensitive
to LY 303070, a specific AMPA receptor antagonist
(Malva et al., 1998). Moreover, NMDA receptors and
voltage-sensitive Na channels are not involved in the
increase in the [Na]i caused by kainate, probably
because NMDA receptors are blocked by Mg2 and
Na channels are inactivated. Thus, in our system and
in the situations tested, the main pathway for the influx
of Na due to stimulation with kainate are non-
NMDA receptors. CBZ did not inhibit the [Na]i
signal due to the glutamate ionotropic receptor ago-
nists. This result suggests that CBZ does not inhibit
glutamate ionotropic receptor channels, and further
supports the effect of CBZ on VSCCs. The drug (400
mM) failed to affect Na-dependent binding of [3H]L-
glutamate to hippocampal synaptic membranes (Olpe et
al., 1985). We also observed that CBZ inhibited the
increase in the [Na]i stimulated by veratridine (data
not shown), confirming its effects on Na channels,
which are not involved in the present stimulation
protocol.
Taken together, the present data show that L-type
Ca2 channels are the main target of CBZ. These
effects may also be responsible for the neuroprotective
effects of the drug, in agreement with Lakics et al.
(1995), who suggested that mechanisms other than
sodium channel blockade may be involved in the neuro-
protection. Our results also suggest that glutamate
ionotropic receptors are not directly affected by this
AED.
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